212 men supplemented with CoQ10 or placebo for 26 weeks.
Supplementing with coenzyme Q10 (CoQ10) may alleviate male infertility, according to a recently published study.
CoQ10 is an antioxidant involved in the production of energy. It is found in naturally high amounts in key organs, such as the heart. CoQ10 deficiencies have been linked to a variety of adverse health factors, including gum disease and heart disease.
Writing in The Journal of Urology, Iranian researchers looked at a potential benefit of CoQ10 supplementation for infertile men suffering from idiopathic oligoasthenoteratozoospermia, a condition of having insufficient spermatozoa levels and reduced sperm movement towards the egg. A total of 212 men supplemented with 300 mg of CoQ10 (supplied as KanekaQ10) or placebo daily for 26 weeks, followed by 30 weeks without supplementation of any kind.
Researchers observed improvements in sperm density, sperm motility, and sperm morphology complared to placebo, yet no significant improvement in rate of pregnancy.
“This study indicates that oral supplementation with CoQ10 significantly improves semen parameters compared with that of placebo,” wrote the study’s author. “Although this observation may not be clinically relevant, we propose that because of its antioxidant effects and safety profile, CoQ10 should be considered a good candidate for treatment in infertile men with idiopathic oligoasthenoteratospermia. A longer term study with different treatment regimens is needed to draw a final conclusion.”
Driving Sustainability in Nutraceuticals: How Ingredient Brands Are Raising the Bar
April 26th 2024Health-minded consumers, especially Generation Z, value nutraceutical companies with sustainability embedded into their corporate philosophy—from product development to packaging. This article discusses how responsible companies are responding to the consumer call for greater sustainability by implementing environmentally friendly manufacturing practices that ultimately lead to waste reduction, improved supplier communications and lower supply chain risk. Those who have taken steps to demonstrate a genuine commitment to sustainability are standing out with improved outcomes for all.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.